⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for molecular biology

Every month we try and update this database with for molecular biology cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix CancerNCT05102240
Cervix Cancer
18 Years - 90 YearsTata Memorial Hospital
Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )NCT04249895
All Cancer
- Tata Medical Center
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix CancerNCT05102240
Cervix Cancer
18 Years - 90 YearsTata Memorial Hospital
Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )NCT04249895
All Cancer
- Tata Medical Center
Molecular Biology of Anal Cancer in HIV-Positive PatientsNCT00952874
Carcinoma
HIV Infections
20 Years - 80 YearsUniversity Hospital, Geneva
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersNCT02600442
Breast Neoplasm...
Breast Cancer
non interventio...
- Assistance Publique - Hôpitaux de Paris
Molecular and Histological Characteristics of Serrated Lesions of the ColonNCT03089268
Colonic Neoplas...
Colorectal Canc...
Sessile Serrate...
Polyp of Colon
Colonoscopy
Polypectomy or ...
Molecular analy...
50 Years - 75 YearsHospital Universitario La Fe
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix CancerNCT05102240
Cervix Cancer
18 Years - 90 YearsTata Memorial Hospital
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersNCT02600442
Breast Neoplasm...
Breast Cancer
non interventio...
- Assistance Publique - Hôpitaux de Paris
Molecular Markers in Cancers and Precancers (MOCA)NCT05257707
Cancer
Precancerous Le...
Healthy
Molecular biolo...
18 Years - Centre Hospitalier Universitaire de Besancon
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: